Skip to main content

A ray of hope for arthritis




​Thanks to ancient science Ayurveda which came up with a unique wonder drug under the name of S.Compound.

Work on herb was started in the year 1974 and ultimately it was confirmed that the herb has great potential in inflammatory conditions. However, its role on arthritis was explored because it was the most neglected disease by the scientists and Medical fraternity. The available pain killers were causing huge harm to our body systems and some of the available pain killers were even banned in Europe.
The herbal medicine S.Compound was compared with Phenylbutazone by the scientists of Central Drug Research Institute Lucknow in the year 1983 and was found better in efficacy

Controlled Clinical trials were carried out on human beings suffering from Rheumatoid arthritis; Is not only its efficacy was confirmed but it was also found safe in long duration. The research work was published in Eastern Pharmacist which was reported by country's premier News Agency United News of India on 21.06.1982 0under the caption: Hope for arthritis patients. 

The news states Jammu Pharmaceutical firm has developed an Ayurvedic Medicine that may prove a ray of hope for arthritis patients. It was observed during trials conducted in patients suffering from chronic Rheumatoid arthritis that the drug afforded between 70 and 80 percent relief with regard to swelling in joints and tenderness, morning stiffness, walking time and patients own impression of overall disease activity. According to Eastern Pharmacist, a leading pharmaceutical journal, it appears that the drug acts on the basic pathological process responsible for the genesis of Rheumatoid arthritis.

Due to coverage in large number of Indian News Papers, Indian Health Minister gave. A statement in November 1983 that Rahul Pharma Jammu developed an Ayurvedic drug in the name of S.Compound .The main ingredient of the drug is Salai sGuggul. This drug is claimed to be very effective for the treatment of Rheumatoid arthritis.

Former Union Minister of State for Commerce Shantilal Patel while speaking to Indian Express on 29.05.2004 stated that Arthritis is one of the most painful diseases and has increased many folds due to change in life style of people, he said,based on his experiences, that the persons who live a sedentary life are the most affected people.

Continue reading​

Comments

Post a Comment

Popular posts from this blog

BE guidelines regarding investigator

BE guidelines recommend investigator should possess appropriate medical qualification, experience for conducting pharmacokinetic studies Can chairperson of EC directly write to sponsor to clarify some of the queries of clinical trial raised in EC meeting? Dr. Sreevatsa Please see an extract from FDA's comment on IRB-sponsor relationship. The interrelationship and interaction between the research sponsor (e.g., drug, biologic and device manufacturers), the clinical investigator and the Institutional Review Board (IRB) may be very complex. The regulations do not prohibit direct sponsor-IRB contacts, although, the sponsor-IRB interaction customarily occurs through the investigator who conducts the clinical study. The clinical investigator generally provides the communication link between the IRB and the sponsor. Such linkage is agreed to by the sponsors and investigators when they sign forms FDA-1571 and FDA-1572, respectively, for drug and biologic studies or a...
Post a Comment
Read more

ICH GCP requires EC members to be independent of investigator and sponsor to avoid conflicts of interest

Can an Ethics Committee member e.g. layman/chairman or anyone in the committee participate in the trial as a subject? Vidya If an Ethics Committee member becomes a trial subject on a trial that he/she was involved in approving then there has been a major conflict of interest. The following situations need to be considered: ● IEC member reviews study without any prior knowledge of the study, votes, and then afterwards is approached by clinical research team to participate. Possibly this is OK but the member should no longer be part of the IEC that reviews that study. This will be difficult in practice, so therefore it is not advisable. ● IEC member already knows about the study and is voting in order to be able to participate. This is clearly not acceptable and made worse if there is additional financial incentive for the study (e.g. volunteer study). ICH GCP requires Ethics Committee members to be independent of the investigator and the sponsor to avoid confl...
Post a Comment
Read more

Combination Vaccine for Kids withdrawn

A vaccine that combines conventional MMR (Measles, Mumps, Rubella) with Chikenpox has been withdrawn in the United States due to a higher rate of seizures in children. In a study children aged 12 to 23 months who received the combined MMR cum Chickenpox vaccine had double the rate of seizures compared to children who got separate vaccine for MMR and chickenpox. This equates to one additional case of convulsion per 2000 vaccinations.
Post a Comment
Read more